KEW

KEW, Inc. provides genomic testing services that enable oncologists to make evidence-driven, personalized treatment decisions for cancer patients. It utilizes CANCERPLEX, a precision medicine testing service with flexible panel sizes that uses each patients genetic drivers to help oncologists choose a personalized, targeted cancer therapy. The company is headquartered in Cambridge, Massachusetts.